logo

For the Inventor, By the Inventor

Dunedin, New Zealand

Pacific Edge Limited


USPTO Granted Patents = 16



Trademarks = 6

Forward Citations = 33

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Parry John Guilford (13 out of 14 patents)

silverMedal Michael Alan Black (5 out of 5 patents)

bronzeMedal Mark Dalphin (3 out of 3 patents)

4.  Laimonis Kavalieris (3 out of 3 patents)

5.  Paul O'Sullivan (3 out of 3 patents)

6.  Robert Craig Pollock (3 out of 3 patents)

7.  Jonathan Cebon (3 out of 5 patents)

8.  Thomas John (3 out of 4 patents)

9.  Hjalmar Nekarda (2 out of 2 patents)

10.  Jan Friederichs (2 out of 2 patents)

11.  Bernhard Holzmann (2 out of 2 patents)

12.  Robert Rosenberg (2 out of 2 patents)

13.  Anthony Edmund Reeve (2 out of 3 patents)

14.  John Lindsay McCall (2 out of 2 patents)

15.  Yu-Hsin Lin (2 out of 2 patents)


16 patents:

1. 11208698 - Methods for detection of markers bladder cancer and inflammatory conditions of the bladder and treatment thereof (2021-12-28),
2. 11180815 - Methods for treating colorectal cancer using prognostic genetic markers (2021-11-23),
3. 11130789 - Urine markers for detection of bladder cancer (2021-09-28),
4. 10689711 - Test kits and methods for their use to detect genetic markers for urothelial carcinoma of the bladder and treatment thereof (2020-06-23),
5. 10689707 - Treatment of recurrent gastric cancer identified using genetic biomarkers (2020-06-23),
6. 10422005 - Methods for treating colorectal cancer using prognostic genetic markers (2019-09-24),
7. 10266902 - Methods for prognosis prediction for melanoma cancer (2019-04-23),
8. 10179935 - Markers for detection of gastric cancer (2019-01-15),
9. 10131955 - Methods for detecting genetic and phenotypic biomarkers of urothelial carcinoma and treatment thereof (2018-11-20),
10. 10024859 - Markers for detection of gastric cancer (2018-07-17),
11. 9982305 - Polymerase chain reaction test kits for detecting markers of bladder cancer (2018-05-29),
12. 9809860 - Test kits and methods for their use in detecting expression ratios of genetic markers (2017-11-07),
13. 9702009 - Urine gene expression ratios for detection of cancer (2017-07-11),
14. 9534258 - Devices and methods for prognosis prediction for melanoma cancer (2017-01-03),
15. 9310370 - Markers for detection of gastric cancer (2016-04-12),
Pacific Edge Limited is a New Zealand-based cancer diagnostics company specializing in molecular diagnostics testing. The company aims to improve patient outcomes through accurate and non-invasive diagnostic tools for the early detection and monitoring of cancer. Their innovative Cxbladder technology enables the detection of bladder cancer with high accuracy, reducing the need for more invasive procedures. Pacific Edge is committed to advancing personalized medicine and improving healthcare outcomes worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

16 Patents

#2 in Dunedin

#42 in New Zealand

#36,704 in the World

...
Dunedin, New Zealand

Pacific Edge Limited

Forward Citations = 33

20 inventors:

goldMedal Parry John Guilford (13 out of 14 patents)

silverMedal Michael Alan Black (5 out of 5 patents)

bronzeMedal Mark Dalphin (3 out of 3 patents)

4.  Laimonis Kavalieris (3 out of 3 patents)

5.  Paul O'Sullivan (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…